Summary – Revealing Nature’s Pharmacy: The Future of Pharmaceuticals with Biosortia with Ross Youngs Episode 96. Dive into our latest episode, in which we explore the groundbreaking realm of Biosortia Pharmaceuticals and their innovative journey through microbiome mining. This isn’t just about science; it’s about reshaping healthcare. Discover a future where the smallest organisms could hold the key to our biggest health challenges.
Forbion Portfolio Company Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer (May 2, 2024) | By Laura Asbjornsen, Portfolio News. Exciting news today for Forbion portfolio company Mariana Oncology. The company announces a landmark acquisition deal with Novartis worth $1 billion in cash upfront and up to $750 million in potential milestone payments. This
